A comparative trial of hyposensitization in 1973 in the treatment of hay fever using Pollinex and Alavac‐P
- 1 November 1976
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 6 (6) , 551-556
- https://doi.org/10.1111/j.1365-2222.1976.tb01940.x
Abstract
Summary: A direct comparison was made in 112 hay fever patients of hyposensitization treatment with glutaraldehyde‐pollen‐tyrosine adsorbate (Pollinex) and with alum‐precipitated pyridine extract (Alavac‐P) which is an accepted form of treatment, its efficacy having been shown by a comparative trial against a placebo preparation.No significant difference could be detected between the results of the two forms of treatment. Seventy‐seven per cent of patients responded with improvement following treatment with the tyrosine adsorbed vaccine, and 81% of those receiving the alum‐precipitated vaccine. Side effects from treatment, both local and general, were generally of an infrequent or mild nature for both vaccines.This publication has 6 references indexed in Scilit:
- IgE, IgG and patient-self tests during slow hyposensitization to grass pollenClinical and Experimental Allergy, 1975
- Expérience clinique en belgique pendant la saison pollinique 1973 avec un extrait de pollen adsorbé sur tyrosineRevue Française d'Allergologie et d'Immunologie Clinique, 1975
- Glutaraldehyde‐pollen‐tyrosine: clinical and immunological studiesClinical and Experimental Allergy, 1974
- A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbateClinical and Experimental Allergy, 1974
- A Controlled Trial of Pollen Adsorbate in the Treatment of Hay FeverScottish Medical Journal, 1963